Asciminib with or without sildenafil for brain tumors
Treatments studied
Part of Brain & nervous system, Cancer clinical trials.
This trial is testing two drugs (asciminib alone or with sildenafil) for people with brain tumors that have come back or are growing. The goal is to see if these drugs can help shrink or control the tumor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 39 years old.
- You have a brain tumor that has come back or is growing (shown on scans).
- The tumor is located mainly within the brain tissue (not in the lining or pituitary).
- You are able to have surgery or a biopsy to remove or sample the tumor.
- Your blood counts (white cells, platelets, and hemoglobin) are at safe levels.
- Your kidney and liver function are within acceptable limits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a drug called sotorasib in people with brain tumors who are already scheduled for surgery or a biopsy. It may help find out if the drug can reach and treat the tumor.
This trial tests the drug asciminib for people with HER2-positive breast cancer that has spread to the brain and is growing. It may be an option if you have already tried standard treatments like T-DXd and tucatinib.
This Phase 2 study tests sintilimab (an anti–PD-1 immune medicine) given with low-dose bevacizumab to treat astrocytoma that has returned. It also measures a blood/tumor fluid signal (ctDNA level) and uses specialized post-surgery fluid collection to see how well treatment works and monitors safety.
This trial tests an experimental drug, BMS-986504, for people with recurrent glioblastoma (a type of brain cancer). The drug targets a specific genetic change in the tumor. It aims to see if the drug can help shrink or slow the tumor.
This trial tests a drug called Belvarafenib for people with brain tumors that have a BRAF gene change (mutation). The drug targets this specific change to try to shrink or control the tumor. It is for patients whose brain tumor has come back or hasn't responded to other treatments.
This trial studies silibinin, a natural substance, to help prevent brain metastasis from coming back after surgery. It is for people with lung (NSCLC) or breast cancer who have exactly one small brain metastasis that is fully removed and has a specific lab marker in the brain tissue.
Hear when a new Brain Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.